Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

PharmaData

PharmaData are award-winning specialists in pharmaceutical data analytics driving strategy, engaging teams and measuring change across Australia and Europe. Our proprietary products help our clients identify and act on opportunities to; increase generic substitution, improve efficiency, engage sales forces, drive strategy, build ‘sticky’ business relationships, achieve greater depth in market, encourage customer loyalty and help deliver more patient centric care.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

Genetic Digital

We guide healthcare and life sciences organisations through digital transformation. Simplifying the complex world of tech and marketing, we create impactful assets and strategies to drive long-term growth and positive…

View Profile

Creative and design, Digital communications, IT solutions, Marketing consultancies, Medical communications

- PMLiVE

Nmblr

From day-one concept to launch and beyond, Nmblr is the strategy and collaboration platform that partners with biopharma teams.

View Profile

IT solutions

Company Details

PharmaData
The Limestore, Level 1 33 Longland Street, Newstead, Queensland, 4006, Australia
+617 3171 9900
Contact PharmaData
Website

 Latest Content from PMHub 

Blog: The Cost of Counterfeits

White Papers and Resources | August 12, 2016 | Inizio

The sale of counterfeit drugs is growing at twice the rate of legitimate pharmaceuticals and pharma companies stand to lose more than just profits from the fallout of counterfeit identification.

Video: Self-pay and Emerging Markets

White Papers and Resources | August 12, 2016 | Inizio

A key feature of emerging markets is that patients often have to pay for a high proportion of their healthcare costs themselves. For all but the most severe conditions, public...

News: Therapy Watch HCV expands into 4 additional EU markets

White Papers and Resources | August 12, 2016 | Inizio

The HCV market has been growing and changing remarkably quickly and with the development of new and improving drugs, the treatment of HCV has moved on in a short space...

News: Research Partnership launches new patient report – Living with Ulcerative Colitis

White Papers and Resources | August 12, 2016 | Inizio

Living with UC is a quantitative study conducted online amongst 325 patients, including both adult and paediatric patients diagnosed with ulcerative colitis in 5 EU markets (France, Germany, Italy, Spain...

Summer Intern experience at Research Partnership

White Papers and Resources | August 12, 2016 | Inizio

We look for bright and inquisitive people who want to learn in a company that's pushing the boundaries of pharmaceutical market research

Health Unlimited announces partnership with HealthUnlocked to expand direct-to-consumer insight and engagement

Press Releases | August 12, 2016 | Health Unlimited

London, 12th August 2016. Health Unlimited, the specialist healthcare marketing communications group, part of Creston Unlimited, today announces a global partnership agreement with HealthUnlocked.

What kind of customer data are you getting?

White Papers and Resources | August 10, 2016 | Anthill Agency

How to collect the proper data to discover how to act next.

Products as portfolios: positioning immuno-oncology products

White Papers and Resources | August 9, 2016 | Blue Latitude Health

The last few years have seen a huge proliferation in the number of products entering the oncology space, with a lot more currently being investigated in clinical trials. Effective positioning...

Making a difference together

Press Releases | August 8, 2016 | Lucid Group Communications Limited

It was highlighted at the 2016 World Economic Forum that ‘good business’ now means more than financial success, with multiple stakeholders asking how business will benefit society. At Lucid, our...

Immunotherapy in oncology

White Papers and Resources | August 5, 2016 | Blue Latitude Health

Consultant David Cooney explores the medical insights, unmet needs, and future of the vastly growing area of immunotherapy as the fourth pillar in oncology.